Literature DB >> 7154133

[Irritation test of dexamethasone valerate (DV-17) and other steroid ointments in rabbits. Skin and eye primary irritation tests, and skin cumulative irritation test].

T Shimo, M Yamazaki, Y Noguchi, A Mukawa, H Kato, Y Ito.   

Abstract

The skin and eye primary irritation tests, and skin cumulative irritation test were performed on male rabbits, which were topically treated with a volume of 1 g/body of 0.06% and 0.12% dexamethasone valerate (DV-17) ointments as a test drug, and 0.1% hydrocortisone butyrate (HB) and 0.12% betamethasone valerate (BMV) ointments as an active control drug in order to evaluate the topical and systemic effects. No skin and eye primary irritations except minimal skin erythema and slight conjunctival redness were seen in above four corticosteroids. Judging from the results such as skin atrophy, inhibition of body weight gains, and decreases of thymus, spleen and adrenal weights, the potency of toxicities among the four corticosteroid ointments appeared to be as follows: 0.12% DV-17, 0.12% BMV greater than 0.1% HB greater than 0.06% DV-17.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7154133     DOI: 10.2131/jts.7.supplementi_1

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  2 in total

1.  Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.

Authors:  Xiaoyan Yang; Sulabh Patel; Ye Sheng; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-02-07       Impact factor: 3.246

2.  Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.

Authors:  Xiaoyan Yang; Hoang M Trinh; Vibhuti Agrahari; Ye Sheng; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2015-06-18       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.